ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 025,38
0,36%
Dow Jones
38 852,27
0,46%
DAX
18 311,29
0,77%
Brent Oil
82,87
-0,72%
Bitcoin
64 058,12
1,41%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Selecta Biosciences Inc (SELB)

  7. Selecta Biosciences Inc (SELB) Actualités

SELB Selecta Biosciences Inc

0,8812
0,00 (0,00%)
Avant marché
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Selecta Biosciences Inc SELB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,8812 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,8812
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202415:09EDGAR2Form DEF 14A - Other definitive proxy statements
26/4/202413:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/4/202412:25EDGAR2Form 8-K - Current report
19/4/202422:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/4/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/4/202422:29EDGAR2Form SC 13D/A - General statement of acquisition of..
10/4/202422:25EDGAR2Form SC 13D/A - General statement of acquisition of..
10/4/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/4/202413:00EDGAR2Form 8-K - Current report
01/4/202422:32EDGAR2Form 8-K - Current report
28/3/202422:00EDGAR2Form 8-K - Current report
14/3/202412:55EDGAR2Form 8-K - Current report
07/3/202413:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202413:06EDGAR2Form 8-K - Current report
05/3/202413:05EDGAR2Form 8-K - Current report
14/2/202423:27EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/2/202422:42EDGAR2Form DEF 14A - Other definitive proxy statements
14/2/202418:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:30EDGAR2Form PRE 14A - Other preliminary proxy statements
23/1/202422:05EDGAR2Form 8-K/A - Current report: [Amend]
19/1/202422:12EDGAR2Form 8-K - Current report
12/1/202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202414:45EDGAR2Form 8-K - Current report
08/1/202413:10GLOBECartesian Therapeutics Highlights Progress and 2024..
08/1/202413:00GLOBECartesian Therapeutics Announces Positive Long-Term..
04/1/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:28EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
04/12/202322:39EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
01/12/202314:31EDGAR2Form S-3/A - Registration statement under Securities Act of..
27/11/202322:18EDGAR2Form 8-K - Current report
22/11/202322:39EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/11/202322:38EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/11/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
SELB
Selecta Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés